COVIran Barekat[1] is a COVID-19 vaccine developed in Iran by Shifa Pharmed Industrial Group, a subsidiary of the Barkat Pharmaceutical Group.[2][3][4] It is an inactivated virus-based vaccine.[1] It has been authorized for emergency use by the Iranian authorities. This makes it the first locally-developed COVID-19 vaccine to be approved for emergency use in the Middle East.[5]